- Home
- MED vs IPHA Comparison
MED vs IPHA Comparison
Compare MED & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- IPHA
- Stock Information
- Founded
- MED 1980
- IPHA 1999
- Country
- MED United States
- IPHA France
- Employees
- MED N/A
- IPHA N/A
- Industry
- MED Packaged Foods
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- IPHA Health Care
- Exchange
- MED Nasdaq
- IPHA Nasdaq
- Market Cap
- MED 152.3M
- IPHA 160.1M
- IPO Year
- MED N/A
- IPHA 2019
- Fundamental
- Price
- MED $14.58
- IPHA N/A
- Analyst Decision
- MED Hold
- IPHA Strong Buy
- Analyst Count
- MED 1
- IPHA 1
- Target Price
- MED $16.50
- IPHA $11.00
- AVG Volume (30 Days)
- MED 279.2K
- IPHA 11.7K
- Earning Date
- MED 08-04-2025
- IPHA 03-27-2025
- Dividend Yield
- MED N/A
- IPHA N/A
- EPS Growth
- MED N/A
- IPHA N/A
- EPS
- MED N/A
- IPHA N/A
- Revenue
- MED $543,452,000.00
- IPHA $20,831,349.00
- Revenue This Year
- MED N/A
- IPHA $209.83
- Revenue Next Year
- MED N/A
- IPHA $83.15
- P/E Ratio
- MED N/A
- IPHA N/A
- Revenue Growth
- MED N/A
- IPHA N/A
- 52 Week Low
- MED $11.57
- IPHA $1.29
- 52 Week High
- MED $22.66
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- MED 60.09
- IPHA 39.24
- Support Level
- MED $12.95
- IPHA $1.71
- Resistance Level
- MED $14.90
- IPHA $1.90
- Average True Range (ATR)
- MED 0.67
- IPHA 0.09
- MACD
- MED 0.12
- IPHA -0.00
- Stochastic Oscillator
- MED 83.98
- IPHA 40.74
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.